Biocartis Group NV: BIOCARTIS SUCCESSFULLY RAISES EUR 55.50 MILLION

   PRESS RELEASE: REGULATED INFORMATION - INSIDE INFORMATION23 January 2019, 21:30 CETBIOCARTIS SUCCESSFULLY RAISES ...

Biocartis Group NV: BIOCARTIS UPSIZES ITS EQUITY PLACEMENT DUE TO SIGNIFICANT DEMAND

    PRESS RELEASE: REGULATED INFORMATION - INSIDE INFORMATION23 January 2019, 17:15 CETBIOCARTIS UPSIZES ...

Rexahn Announces Pricing of Public Offering of Common Stock and Warrants

ROCKVILLE, Md., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN) ...

Biocartis Group NV: BIOCARTIS LAUNCHES EQUITY PLACEMENT

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF ...

Biocartis Group NV: BIOCARTIS LAUNCHES EQUITY PLACEMENT

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF ...

Telix Pharmaceuticals Launches illumet™ Microsite (Kit for the Preparation of 68Ga-PSMA)

MELBOURNE, Australia and INDIANAPOLIS, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix ...

Telix Pharmaceuticals Launches illumet™ Microsite (Kit for the Preparation of 68Ga-PSMA)

MELBOURNE, Australia and INDIANAPOLIS, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix ...